Article Information
History
- August 10, 2022.
Article Versions
- You are currently viewing Version 1 of this article (August 10, 2022 - 15:43).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ping Ren2,3,*,
- Yingxia Hu4,*,
- Lei Peng1,2,3,@,
- Luojia Yang1,2,3,4,
- Kazushi Suzuki1,2,3,
- Zhenhao Fang1,2,3,
- Meizhu Bai1,2,3,
- Liqun Zhou1,2,3,5,
- Yanzhi Feng1,2,3,5,
- Yong Xiong4,@ and
- Sidi Chen1,2,3,4,5,6,7,8,@
- 1Department of Genetics, Yale University School of Medicine, New Haven, CT, USA
- 2System Biology Institute, Yale University, West Haven, CT, USA
- 3Center for Cancer Systems Biology, Yale University, West Haven, CT, USA
- 4Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA
- 5Molecular Cell Biology, Genetics, and Development Program, Yale University, New Haven, CT, USA
- 6Immunobiology Program, Yale University, New Haven, CT, USA
- 7Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA
- 8Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA
- 9Center for Biomedical Data Science, Yale University School of Medicine, New Haven, CT, USA
- ↵@Correspondence: SC (sidi.chen{at}yale.edu), +1-203-737-3825 (office), +1-203-737-4952 (lab), YX (yong.xiong{at}yale.edu), +1 (203) 436-2609 (lab)
Posted August 10, 2022.
Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
